ARTICLES BY TYLER MENICHIELLO
-
Unlocking The Pharmacological Potential Of Antibodies8/20/2025
Abalone Bio's CEO and co-founder, Richard Yu, Ph.D., explains the company's Functional Antibody Selection Technology (FAST) platform and its approach to developing a pipeline of G protein-coupled receptor (GPCR) mAbs.